Clinical Trial Update: Evaluation of the Effects of Local Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Adjuvant Administration on Dendritic Cells in Skin of Melanoma Patients and in Sentinel Lymph Nodes: MEL38 [NA]

View source ↗

Summary

A completed clinical trial (MEL38) evaluated local GM-CSF as an adjuvant in melanoma patients, analyzing dendritic cell effects in the skin and sentinel lymph n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) (sargramostim)

Snippet

Sponsor: University of Virginia | Conditions: Melanoma | NA | Status: COMPLETED